Showing results (1841-1850 of 1,922) with videos related to
Sort By:
Pageof 193
Nature Biotechnology|August 1, 2024
Enhancing siRNA efficacy in vivo with extended nucleic acid backbonesKen Yamada, Vignesh N Hariharan, Jillian Caiazzi, et al.Plos Medicine|April 13, 2016
Mobile Phones As Surveillance Tools: Implementing and Evaluating a Large-Scale Intersectoral Surveillance System for Rabies in TanzaniaZacharia Mtema, Joel Changalucha, Sarah Cleaveland, et al.Proceedings of the National Academy of Sciences of the United States of America|July 27, 2016
Unraveling the drivers of MERS-CoV transmissionSimon Cauchemez, Pierre Nouvellet, Anne Cori, et al.Wellcome Open Research|September 21, 2020
Anonymised and aggregated crowd level mobility data from mobile phones suggests that initial compliance with COVID-19 social distancing interventions was high and geographically consistent across the UKBenjamin Jeffrey, Caroline E Walters, Kylie E C Ainslie, et al.Communications Biology|November 28, 2020
A pleurocidin analogue with greater conformational flexibility, enhanced antimicrobial potency and in vivo therapeutic efficacyGiorgia Manzo, Charlotte K Hind, Philip M Ferguson, et al.Organic & Biomolecular Chemistry|January 19, 2019
Enhancing T cell responses and tumour immunity by vaccination with peptides conjugated to a weak NKT cell agonistBenjamin J Compton, Kathryn J Farrand, Ching-Wen Tang, et al.The British Journal of Dermatology|October 11, 2024
Comprehensive mutational profiling identifies new driver events in cutaneous leiomyosarcomaLouise van der Weyden, Martin Del Castillo Velasco-Herrera, Saamin Cheema, et al.ACS Chemical Biology|August 14, 2018
Structural and Atropisomeric Factors Governing the Selectivity of Pyrimido-benzodiazipinones as Inhibitors of Kinases and BromodomainsJinhua Wang, Tatiana Erazo, Fleur M Ferguson, et al.Molecular Cancer Therapeutics|November 24, 2021
STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic TumorsSamanthi A Perera, Johnny E Kopinja, Yanhong Ma, et al.The Prostate|March 7, 2024
Defining the challenges and opportunities for using patient-derived models in prostate cancer researchW Nathaniel Brennen, Clémentine Le Magnen, Sofia Karkampouna, et al.Pageof 193